Form 4 holding
10%+ Owner
Tempest Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 2,118,644
- Estimated value
- $10,127,118
- Report date
- 29 Apr 2022
- Price
- $4.78
- Ownership
- Direct
Versant Vantage II, L.P.
Insider Reports History
- Reporting-owner location
- San Francisco, CA
- Latest reporting-owner signature
-
Versant Vantage II, L.P., By: Versant Vantage II GP, L.P. Its: General Partner, By: Versant Vantage II GP-GP, LLC Its: General Partner, By: /s/ Robin L. Praeger Its: Managing Director
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Versant Vantage II, L.P.
Insider Reports Filed by Versant Vantage II, L.P.
3
TPST
Tempest Therapeutics, Inc.
- Report period
- 29 Apr 2022
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 03 May 2022, 17:07
- Role
- 10%+ Owner
- Next action
- Open filing details